Empresa Brainstorm Cell Therapeutics Inc OTC Bulletin Board
Acciones
US10501E1029
Biotecnología e investigación médica
Precio de cierre
Otros sitios de cotización
|
||
- USD | - |
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Chaim Lebovits
CEO | Chief Executive Officer | 53 | 01/07/07 |
Alla Patlis
DFI | Director of Finance/CFO | 37 | 23/12/12 |
Chief Tech/Sci/R&D Officer | - | 12/05/22 | |
Bob Dagher
CTO | Chief Tech/Sci/R&D Officer | 55 | 17/07/23 |
Yael Gothelf
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/07 |
Stacy Lindborg
BRD | Director/Board Member | 53 | 01/06/20 |
Uri Yablonka
BRD | Director/Board Member | 47 | 06/06/14 |
General Counsel | - | 12/05/22 | |
Mary Kay Turner
LAW | General Counsel | - | 07/08/17 |
Yossef Levy
PRN | Corporate Officer/Principal | - | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Irit Arbel
FOU | Founder | 64 | 22/09/00 |
Uri Yablonka
BRD | Director/Board Member | 47 | 06/06/14 |
Jacob Frenkel
CHM | Chairman | 81 | 30/03/20 |
Director/Board Member | 63 | 28/10/21 | |
Director/Board Member | 61 | 05/02/18 | |
Stacy Lindborg
BRD | Director/Board Member | 53 | 01/06/20 |
Nir Naor
BRD | Director/Board Member | 50 | 20/06/23 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 68 341 857 | 59 269 308 ( 86,72 %) | 0 | 86,72 % |
Información de la empresa
Brainstorm Cell Therapeutics, Inc.
1325 Avenue of Americas 28th floor
10019, New York
+201 488 0460
http://www.brainstorm-cell.comSector
Varia. 1 de ene. | Capi. | |
---|---|---|
+17,96 % | 44,96 mil M | |
+1,17 % | 42,65 mil M | |
+48,77 % | 41,85 mil M | |
-4,27 % | 29,04 mil M | |
+11,42 % | 26,08 mil M | |
-21,39 % | 19,03 mil M | |
+4,86 % | 12,75 mil M | |
+27,29 % | 12,06 mil M | |
-3,50 % | 11,75 mil M |
- Bolsa de valores
- Acciones
- Acción BCLI
- Acción
- Empresa Brainstorm Cell Therapeutics Inc